Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

p21 gene activator saRNA RAG-01

A small activating RNA (saRNA) targeting the tumor suppressor gene p21, with potential antineoplastic activity. Upon intravesical instillation of p21 gene activator saRNA RAG-01, the saRNA targets and activates the expression of the p21 gene and restores p21 therapeutic protein levels. This may decrease bladder tumor cell growth. Downregulation of p21 plays a key role in tumorigenesis. p21 is crucial for regulating the progression of the cell cycle and plays an essential role in halting the proliferation of cancer cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	RAG 01 RAG-01 RAG01

p21 gene activator saRNA RAG-01

Search NCI's Drug Dictionary